Home | About Us

Premier Life Sciences Strategy Consulting

We merge the art of innovative thinking with the science of strategic consulting.

Founded in 2012 by industry veterans, Blue Matter has established itself as a leading life sciences strategy consulting firm specializing in the pharmaceutical and biotech sectors. We offer the tools, methodologies, and expertise of a large global consulting firm, while providing the personalized service and creativity of a more agile firm.

We empower life sciences companies to achieve their full potential.

With proven success driving strategy and commercialization forward for some of the world’s most innovative therapies, our client base includes over 250 companies, ranging from start-ups to nearly all of the top 20 global biopharma companies.

3,000+

Projects completed

500+

New projects per year

90%

Repeat business rate

“We know when and how to see the big picture and when and how to dive into the detailed, tactical view of product, portfolio, and corporate strategy.”

Jeron Eaves, Managing Partner

“Introducing a high-cost branded therapy into a disease space that previously had only generics may cause challenges with payer coverage, especially in more prevalent disease areas that have a greater budget impact for payers.”

Julia Margulis, Ph.D, Principal

"To be successful, manufacturers should incorporate commercial considerations into early stage clinical development decision making and be quick to revise program and portfolio strategies as new data and products emerge."

Michael Gottlieb, Principal

“Integrating the commercial perspective into early strategic decision-making is critical when it comes to a company’s long-term success.”

Joe Magliocco, Partner

We leverage diverse perspectives and expertise to make a difference.

The Blue Matter team is composed of seasoned industry veterans, life science strategy consultants, and scientists dedicated to driving innovation and delivering impactful results for our clients across the globe.

Join our team

250+

Team members

33%

PhD/MDs

90%

Advanced degrees

We’re at the forefront of industry trends and technological advancements.

Our in-depth understanding of the pharmaceutical and biotech markets in which we operate enables us to offer recommendations that stand up to the realities and nuances of these complex environments.

View All